See the DrugPatentWatch profile for Sildenafil
The patent expiry for Sildenafil is a key factor in the availability of generic versions of the drug. As patents expire, pharmaceutical companies are able to manufacture and market their own versions of Sildenafil, often at a lower cost.
When Does Sildenafil Go Off Patent?
The original patent for Sildenafil, marketed as Viagra by Pfizer, expired in many major markets around 2013. This led to the introduction of generic Sildenafil in countries like the United States and across Europe. Information on specific patent expiries for various regions and formulations can be found on sites like DrugPatentWatch.com [1].
What Happens When Sildenafil Patents Expire?
Patent expiry allows for the emergence of generic Sildenafil products. These generics must meet the same strict quality and efficacy standards as the brand-name drug set by regulatory bodies like the FDA. The increased competition from generic manufacturers typically drives down prices for consumers.
Who Makes Generic Sildenafil?
Numerous pharmaceutical companies worldwide manufacture and distribute generic Sildenafil. These companies obtain licenses or benefit from patent expiry to produce their versions of the medication.
What are the Differences Between Brand-Name and Generic Sildenafil?
Generic Sildenafil contains the same active ingredient, Sildenafil citrate, in the same dosage and strength as the brand-name product. The primary differences often lie in the inactive ingredients (fillers, binders, colors), which do not affect the drug's safety or effectiveness. Packaging and cost are also differentiating factors, with generics usually being more affordable.
What is the History of Sildenafil Patents?
Pfizer secured the original patent for Sildenafil in the early 1990s. The patent protected the drug's composition of matter and its use for treating erectile dysfunction. The successful defense and eventual expiration of these patents paved the way for generic competition.
What are the Clinical Uses of Sildenafil?
While widely known for its use in treating erectile dysfunction under the brand name Viagra, Sildenafil is also prescribed for pulmonary arterial hypertension (PAH) under the brand name Revatio. In this context, it is used to improve exercise ability in both men and women with PAH. The patent situation and generic availability may differ for these distinct indications.